Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?
Hatzipanagiotou ME, Pigerl M, Gerken M, Räpple S, Zeltner V, Hetterich M, Ugocsai P, Fernandez-Pacheco M, Inwald EC, Klinkhammer-Schalke M, Ortmann O, Seitz S.
Hatzipanagiotou ME, et al. Among authors: hetterich m.
J Cancer Res Clin Oncol. 2023 Oct;149(13):11941-11950. doi: 10.1007/s00432-023-05060-y. Epub 2023 Jul 7.
J Cancer Res Clin Oncol. 2023.
PMID: 37418056
Free PMC article.